Education
About Us
Working with TipRanks
Follow Us
PAWZ - ETF AI Analysis
Top Page
ProShares Pet Care ETF (PAWZ)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Geographic Diversification
The ETF invests in companies across seven countries, reducing reliance on any single market.
Balanced Sector Exposure
The fund is spread across health care, consumer cyclical, and consumer defensive sectors, offering resilience during market shifts.
Reasonable Expense Ratio
With a 0.5% expense ratio, the ETF is competitively priced compared to many niche funds.
Negative Factors
Underperforming Top Holdings
Several key positions, including Freshpet and Zoetis, have shown weak year-to-date performance, dragging on returns.
High Concentration in U.S. Market
Over 65% of the fund is invested in U.S. companies, limiting exposure to international growth opportunities.
Recent Performance Volatility
The ETF has experienced mixed short-term performance, with losses over the last three months despite gains year-to-date.
PAWZ vs. SPDR S&P 500 ETF (SPY)
AUM46.56M
RegionGlobal
Expense Ratio0.50%
Beta0.68
IssuerProShares
Inception DateNov 05, 2018
Dividend Yield0.88%
Asset ClassEquity
Index TrackedFactSet Pet Care Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,669
30 Day Avg. Volume5,471
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
65.88Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering26
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PAWZ Summary
The ProShares Pet Care ETF (Ticker: PAWZ) is an investment fund focused on the growing pet care industry. It tracks the FactSet Pet Care Index, which includes companies involved in pet food, veterinary services, pet insurance, and specialty retailers. Some well-known companies in this ETF are Freshpet and Idexx Laboratories. This ETF might appeal to investors looking for growth opportunities in a niche market driven by increasing pet ownership and spending on pet health and wellness. However, new investors should be aware that the ETF’s performance can fluctuate with changes in consumer spending and trends in the pet care industry.
How much will it cost me?The ProShares Pet Care ETF (PAWZ) has an expense ratio of 0.50%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed and focuses on a niche sector, which typically requires more specialized research and management.
What would affect this ETF?The ProShares Pet Care ETF could benefit from rising global pet ownership and increased spending on pet health and wellness, as pets are increasingly treated as family members. However, economic downturns or higher interest rates could negatively impact consumer spending on non-essential pet products and services, and regulatory changes in the healthcare sector might affect key holdings like Idexx Laboratories and Zoetis. The ETF’s global exposure also makes it sensitive to international market conditions and currency fluctuations.
PAWZ Top 10 Holdings
The ProShares Pet Care ETF (PAWZ) is a niche fund with a global focus on the growing pet care industry, but its performance has been a mixed bag lately. Zoetis and Chewy are dragging the fund, with bearish trends and operational challenges weighing on their stocks. On the brighter side, Freshpet has been rising steadily thanks to strong growth prospects, while Idexx Laboratories and Virbac SA are holding steady with solid financial performance. The ETF leans heavily toward health care and consumer sectors, reflecting its thematic focus on pet wellness and services.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Zoetis | 10.26% | $4.78M | $54.55B | -24.99% | 74 Outperform | |
| Freshpet | 10.02% | $4.67M | $3.12B | -55.56% | 66 Neutral | |
| Chewy | 9.63% | $4.49M | $13.48B | -8.63% | 54 Neutral | |
| Idexx Laboratories | 9.55% | $4.45M | $56.07B | 64.96% | 78 Outperform | |
| Virbac SA | 7.73% | $3.61M | €2.94B | 14.12% | 75 Outperform | |
| CVS Group plc | 4.67% | $2.18M | £897.35M | 53.51% | 66 Neutral | |
| Merck & Company | 4.64% | $2.17M | $259.92B | 5.62% | 80 Outperform | |
| Trupanion | 4.61% | $2.15M | $1.64B | -25.90% | 69 Neutral | |
| Nestlé SA | 4.47% | $2.09M | CHF197.21B | 18.81% | 71 Outperform | |
| Pets at Home | 4.41% | $2.06M | £888.56M | -5.40% | 74 Outperform |
PAWZ Technical Analysis
Neutral
―
Price Trends
54.78
Positive
55.64
Negative
55.45
Negative
Market Momentum
0.09
Negative
51.94
Neutral
47.96
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PAWZ, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 54.92, equal to the 50-day MA of 54.78, and equal to the 200-day MA of 55.45, indicating a neutral trend. The MACD of 0.09 indicates Negative momentum. The RSI at 51.94 is Neutral, neither overbought nor oversold. The STOCH value of 47.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PAWZ.
PAWZ Peer Comparison
Comparison Results
Performance Comparison
PAWZ
ProShares Pet Care ETF
54.89
0.13
0.24%
XAIX
Xtrackers Artificial Intelligence and Big Data ETF
―
―
―
FFND
Future Fund Active ETF
―
―
―
IBLC
iShares Blockchain and Tech ETF
―
―
―
LOGO
Tidal Trust III Alpha Brands Consumption Leaders ETF
―
―
―
OND
ProShares On-Demand ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents